Myositis Induced by Isotretinoin: A Case Report and Literature Review
- PMID: 31958335
- PMCID: PMC6993278
- DOI: 10.12659/AJCR.917801
Myositis Induced by Isotretinoin: A Case Report and Literature Review
Abstract
BACKGROUND Retinoid-induced myositis is a rare condition encountered in clinical practice. Its occurrence implies a diagnostic challenge due to the multiple causes associated with myopathic syndromes. The most common clinical presentation is generalized affection. Focal myositis is even less frequent and easily misdiagnosed as muscular disease of other etiology. CASE REPORT We describe a case of 45-year-old male with a history of nephrolithiasis and rosacea diagnosed by dermatology, who was management with isotretinoin 1 mg/kg per day in 2 doses with clinical improvement. Later, he presents muscle pain in the upper limbs with marked functional limitation associated by choluria, without muscular pains in other location; he had no history of using another medication. At his physical examination, vital signs were normal, with edema and pain in the bilateral bicipital region associated with limitation for flexion-extension of shoulders and elbows and high levels of creatine phosphokinase (CPK). He was transferred to the intensive care unit where he received fluid therapy because of the high risk of deterioration of renal function, very high CPK levels, and a history of obstructive uropathy. One year after this hospitalization, the cutaneous symptoms worsened and the patient voluntarily restarted isotretinoin and 5 months later he presented again with the same symptoms of the first episode. CONCLUSIONS Drug-induced myositis should be taken into consideration in the differential diagnosis of myopathic syndromes. Retinoids have the potential to cause varying degrees of myositis and their rapid identification could prevent major complications.
Conflict of interest statement
None.
Figures

References
-
- Melnik B. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017;97:173–81. - PubMed
-
- Ginsberg H, Rubenstein A, Brown WV. Medical complications of isotretinoin. Clin Dermatol. 1986;4:183–89. - PubMed
-
- Lister RK, Lecky BR, Lewis-Jones MS, Young CA. Acitretin-induced myopathy. Br J Dermatol. 1996;134:989–90. - PubMed
-
- Fiallo P, Tagliapietra AG. Severe acute myopathy induced by isotretinoin. Arch Dermatol. 1996;132:1521–22. - PubMed
-
- Miranda N, Oliveira P, Frade MJ, et al. Myositis with tretinoin. Lancet. 1994;344:1096. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical